Elena Salvaterra ¹ * and Alice Vendramin Bandiera ²

¹ National Coalition of Independent Scholars, NCIS, VT 05301, USA
² Adoces ODV, Verona, Italy

*Corresponding Author:Elena Salvaterra, National Coalition of Independent Scholars, NCIS, VT 05301, USA.

Received: February 02, 2026; Published: February 19, 2026

A shift is taking place in the field of regenerative medicine and transplantation. Recent advances in bioprinting have made available new products, like bio-artificial tissues and organs, that offer to the recipients personalized solutions, reducing surgery duration and fostering tissue regeneration. Though encouraging, these implants raise critical ethical issues that need to be considered carefully. The existing literature identifies critical ethical, legal and social issues such as the body digitalization, rejuvination, immortal life, ownership of artificial bioconstructs, intellectual property rights and social discriminations. However, few publications analyse the ethical problems of early-phase clinical trials and even less articles explore the opinions and the feelings of the stakeholders about the fabrication of bio-artificial organs and their transplantation. In light of this scenario, this research aims to explore the knowledge, opinions, attitudes and hopes of patients and donors towards the bioprinting and organ transplantation by eliciting the underlying ethical feeling. The findings of this study may help to revise the current ethical, legal and social issues related to regenerative surgery based on a bottom up approach by engaging patients and donors. Moreover, it may contribute to develop or review guidelines dedicated to bioprinting and regenerative transplantation.

Keywords: Bioprinting: Regenerative Transplantations; Bioethics; Patient-Centered Approach; Pilot Study; Qualitative Survey

References

1. De Jongh D., et al. “Early-phase clinical trials of bio-artificial organ technology: a systematic review of ethicla issues”. Transplant Intern 35 (2022).
2. Rahim M., et al. “Advances and challenges of biodegradable implants of materials with a focus on magnesium-alloys and bacterial infections”. Metals 8 (2018).
3. Zopf DA., et al. “Bioresorsable airway splint created with a three dimensional printer”. NEJM 368 (2013).
4. Kirillova A. et al. “Bioethical and legal issues in 3D bioprinting”. International Journal of Bioprinting 3 (2020).
5. Tracker Eugene., et al. “The thickness of tissue Engineering: biopolitics, biotechnology and the regenerative body”. Theory and Event 3 (1999).
6. Yudin BG., et al. “Institutionalization of Bioethics and human enhancement”. Workbooks Bioeth 23 (2016).
7. Kusunose M., et al. “Informed consent in clinical trials using stem cells: suggestions and points of attention from informed consent training workshop in Japan”. South African Journal of Bioethics and Law 8 (2015).
8. Trommelman L., et al. “An exploratory survey on the views of tissue engineers concerning the ethical issues of tissue engineering research”. Tissue Engineering. Part B, Reviews 15 (2009).
9. Trommelman L., et al. “Informing participants in clinical trials with ex vivo tissue engineered products: what to tell and how to tell it?”. Journal Tissue Engineering Regen Medicine 2 (2008).
10. Main H., et al. “Potential and pitfalls during clinical translation of emerging stem cell therapies”. Clinical and Translational Medicine 3 (2014).
11. Mohd Aliff A., et al. “Piloting for Interviews in Qualitative Research: Operationalization and Lessons Learnt”. International Journal of Academic Research in Business and Social Sciences 7 (2017).
12. Khin Tandar Aung., et al. “Establishing validity and reliability of semi-structured interview questionnaire in developing risk communication module: a pilot study”. Edunesia Jurnal Ilmiah Pendidikan 2 (2021).
13. Harding J. “Qualitative data analysis from start to finish”. London UK SAGE (2013).
14. The medical expert referred to in this article is Dr. Paolo Rebulla, consulting and former director of the Transfusional Center of the University Polyclinic Hospital in Milan, Italy.
15. Conference Title: “Cellule staminali emopoietiche dal midollo osseo, al sangue cordonale, alla stampa biologica: il presente e il futuro dei trapianti”. Sept. 27, (2025).
16. Italian Law No 2019 of 22th December 2017. Provisions for infomed consent and advance directives. Gazzetta Ufficiale 12 (2018).
17. Personal data protection code updated by Legal decree N. 196/2003.
18. Elliott V. “Thinking about the coding process in qualitative data analysis”. The Qual Report 23 (2018).
19. Atala A., et al. “Tissue engineered autologous bladders for patients needing cystoplasty”. Lancet 364 (2006).
20. Guangdong Zhou., et al. “In vitro regeneration of patient specific ear shaped carilage and its first clinical application for auricular reconstruction”. eBiomedicine 29 (2018).
21. The New York Times. “Doctors transplant ear of human cellsmade by 3D printer”. (2025).
22. Ballantyne A., et al. “Research ethics revised: the new Cioms guidelines and the World medical association declaration of Helsinki in context”. Bioethics 33 (2019).

Citation

Citation: Elena Salvaterra and Alice Vendramin Bandiera. “Bioprinting and Transplantation: A Pilot Qualitative Survey of Knowledge, Perceptions and Hopes of Patients and Donors". Acta Scientific Medical Sciences 10.3 (2026): 03-11.

Copyright

Copyright: © 2026 Elena Salvaterra and Alice Vendramin Bandiera. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.